围绝经期经皮雌二醇联合微粒化黄体酮对动脉疾病风险标志物的影响
这项随机双盲安慰剂对照试验纳入172名45至60岁健康围绝经期及绝经早期女性,比较经皮雌二醇(0.1 mg/天)联合间歇微粒化黄体酮(200 mg/天用12天)与安慰剂治疗12个月对动脉疾病相关机制的影响。结果发现治疗组静息压力反射敏感性有升高趋势,且仅在安慰剂组观察到随年龄出现的血流介导舒张下降和应激反应性升高。
要点
- 经皮雌二醇联合间歇微粒化黄体酮治疗12个月,静息压力反射敏感性较安慰剂有升高趋势
- 仅在安慰剂组观察到随年龄出现的血流介导舒张下降和应激反应性升高
- 治疗组静息舒张压更低、低密度脂蛋白胆固醇更低、应激测试时压力反射敏感性更高
核心结论
- 在健康围绝经期及绝经早期女性中,经皮雌二醇联合间歇微粒化黄体酮有改善心脏自主神经控制的趋势,并防止了随年龄出现的应激反应性和内皮功能变化。
研究设计与样本
- 随机、双盲、安慰剂对照试验,纳入45至60岁健康围绝经期及绝经早期女性172名。
- 受试者随机接受经皮雌二醇0.1 mg/天联合微粒化黄体酮200 mg/天用12天,或相同安慰剂贴片和药片,治疗12个月。
- 结局包括应激反应性复合z评分变化、肱动脉血流介导舒张、压力反射敏感性和代谢风险,在基线及第6、12个月评估。
主要发现
- 在第6和第12个月访视中,经皮雌二醇联合间歇微粒化黄体酮组静息压力反射敏感性较安慰剂组有升高趋势。
- 治疗组与安慰剂组在其他预设结局上无差异。
- 血流介导舒张和应激反应性存在显著的治疗与年龄交互作用:安慰剂组观察到随年龄出现的血流介导舒张下降和应激反应性升高,治疗组未观察到。
- 治疗组静息舒张压更低、低密度脂蛋白胆固醇水平更低、应激测试时压力反射敏感性更高。
临床怎么用
- 原文未据此给出推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The arterial effects of hormone therapy remain controversial. This study tested the effects of transdermal estradiol plus intermittent micronized progesterone (TE + IMP) in healthy perimenopausal and early postmenopausal women on several mechanisms involved in the pathophysiology of arterial disease. METHODS: Healthy perimenopausal and early postmenopausal women, ages 45 to 60 years, were enrolled in this randomized, double-blind, placebo-controlled trial. Women were randomized to receive TE (0.1 mg/day) + IMP (200 mg/day for 12 days) or identical placebo patches and pills for 12 months. Outcomes included: change in stress reactivity composite z-score (combining inflammatory, cortisol, and hemodynamic responses to a standardized psychological laboratory stressor); flow-mediated dilation (FMD) of the brachial artery (an index of vascular endothelial function); baroreflex sensitivity; and metabolic risk (presence of the metabolic syndrome or insulin resistance), all assessed at baseline and at months 6 and 12. RESULTS: Of 172 women enrolled, those assigned to TE + IMP tended to have higher resting baroreflex sensitivity than those assigned to placebo across the 6- and 12-month visits. Although treatment groups did not differ in terms of the other prespecified outcomes, a significant treatment-by-age interaction was found for FMD and stress reactivity such that an age-related decrease in FMD and increase in stress reactivity were seen among women assigned to placebo but not those assigned to TE + IMP. Women on TE + IMP also had lower resting diastolic blood pressure, lower levels of low-density lipoprotein cholesterol, and higher baroreflex sensitivity during stress testing. CONCLUSIONS: TE + IMP tended to improve cardiac autonomic control and prevented age-related changes in stress reactivity and endothelial function among healthy perimenopausal and early postmenopausal women.
引用
- Gordon JL, Rubinow DR, Watkins L, et al. The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease. J Clin Endocrinol Metab. 2020. PMID: 31838497. doi:10.1210/clinem/dgz262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。